Microbot Medical secures first Midwest account, Michigan health system adopts LIBERTY System

Microbot Medical Inc.

First Midwest-based account: a large Michigan healthcare system adopts LIBERTY Endovascular Robotic System.
Follows recent expansion into North Carolina, reflecting growing U.S. presence after full market release.
LIBERTY also received regulatory approval from Israel Ministry of Health to market and sell in Israel.
U.S. market for peripheral endovascular procedures approximately 2.5 million annually.
CEO Harel Gadot cites increasing interest from physicians and hospital leaders.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.